title: [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
abstract: Meningitis caused by Neisseria meningitidis is one of the most frequent and most serious, with fatal rate between few up to 20%. Majority of cases are caused by Neisseria meningitidis of serological groups A, B, C, as well as Y and W 135. Vaccination is the most effective prophylactic measure against meningococcal meningitidis. Polysaccharide, not conjugated vaccines against Neisseria meningitidis serological groups A, C, W 135, Y effective for children over 2 years old, adolescents and adults as well as vaccine against serogroup C conjugated with protein carrier, effective for children over 2 months of life, adolescents and adults are used. Conjugated vaccine against serological group C was used in 1998/1999 in Great Britain in the mass vaccination of infants in 2, 3, 4 months of life, children and adolescents up to 17. In Poland as well as in other European countries serological group B is an etiological factor of majority of cases caused by Neisseria meningitidis. Intensive studies are performed in the field on effective, safety, cheap vaccine against all serological groups of Neisseria meningitidis.
authors.forename: Wiesław
authors.initials: W
authors.lastname: Magdzik
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005060:Europe / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000592:standards; D009345:Neisseria meningitidis / Q000302:isolation & purification; D011044:Poland / Q000453:epidemiology; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage; D018074:Vaccines, Conjugate / Q000008:administration & dosage
chemical_list: D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate